Autotaxin-IN-5
Autotaxin-IN-5 (compound 63), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-5 has the potential to treat idiopathic pulmonary fibrosis[1].
Product Specifications
CAS Number
[2156655-99-9]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/autotaxin-in-5.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCC(N=NN2)=C2C1)CN3N=C(OCC4=CC=CC=C4)C(C5=CN=C(NC6CC7=C(C=CC=C7)C6)N=C5)=C3
Molecular Formula
C30H29N9O2
Molecular Weight
547.61
References & Citations
[1]LEE, Dae Yon, et al. NOVEL COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. WO2018212534A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Autotaxin
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15139493 1 Vial
Lentiviral human PSMA2 shRNA (UAS) - Lentiviral human PSMA2 shRNA (UAS) (25)
Ask
View Details 
